• Chronic Pain
  • Contact
  • Depression
  • Home
  • PTSD
  • Video
Friday, May 27, 2022
  • Login
ketamine.news
Advertisement
  • Home
  • Depression
    ketamine news

    Bronner’s Magic Soaps Becomes The First Company to Offer Ketamine-Assisted Therapy as Part of Employees’ Health Benefits

    ketamine news

    Popular Soap Company–Dr. Bronner’s– Plans To Explore The Psychedelic Space

    ketamine news

    Psychedelic and Plant Medicine Decriminalization Efforts Spread to the Midwest.

    ketamine news

    What There is to Know About Ketamine vs. Electroconvulsive Therapy (ECT)

    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    ketamine news

    Aggregate Study on the Efficacy of Ketamine to Treat Depression Shows Promising Results.

    Flow Integrative - Christi Myers

    Provider Spotlight – Christi Myers, Flow Integrative

    How To Help A Depressed Person

    How To Help A Depressed Person

  • Chronic Pain
    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    Ketamine: A Paradigm Shift in Pain Management

    Ketamine: A Paradigm Shift in Pain Management

    ketamine treatment for depression

    Amidst An Opioid Crisis, Ketamine Has the Potential To Save Lives

    Ketamine for pain

    Multi-Day Low Dose Ketamine Infusion For The Treatment Of Complex Regional Pain Syndrome

    ketamine for chronic pain

    End Chronic Back Pain with Ketamine for a Fuller Life

    ketamine for pain

    What You Should Know About Rheumatoid Arthritis

    ketamine for pain

    Myofascial Pain Syndrome: Symptoms, Causes, and Treatment

    ketamine for pain

    A sweet reprieve: Ketamine helps to relive phantom limb pain

  • PTSD
    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    veterans day

    Veterans’ Day: What Does PTSD Look Like In Veterans?

    PTSD awareness month

    PTSD Awareness Month: What Can I Do To Help?

    Trump Orders ‘a lot’ of Ketamine for Depressed Veterans

    Will Ketamine Be A Breakthrough Drug for PTSD?

    Ketamine to treat ptsd

    PTSD Sufferers ‘Healed’ With New Ketamine Infusion Therapy?

    ketamine to treat PTSD

    VA Uses Ketamine To Treat PTSD Effectively

    ketamine to treat ptsd

    Ketamine can help treat PTSD

  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact
No Result
View All Result
  • Home
  • Depression
    ketamine news

    Bronner’s Magic Soaps Becomes The First Company to Offer Ketamine-Assisted Therapy as Part of Employees’ Health Benefits

    ketamine news

    Popular Soap Company–Dr. Bronner’s– Plans To Explore The Psychedelic Space

    ketamine news

    Psychedelic and Plant Medicine Decriminalization Efforts Spread to the Midwest.

    ketamine news

    What There is to Know About Ketamine vs. Electroconvulsive Therapy (ECT)

    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    ketamine news

    Aggregate Study on the Efficacy of Ketamine to Treat Depression Shows Promising Results.

    Flow Integrative - Christi Myers

    Provider Spotlight – Christi Myers, Flow Integrative

    How To Help A Depressed Person

    How To Help A Depressed Person

  • Chronic Pain
    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    ER Doctor Aims for Patient Centered Breakthrough: A Ketamine That Works Orally

    Ketamine: A Paradigm Shift in Pain Management

    Ketamine: A Paradigm Shift in Pain Management

    ketamine treatment for depression

    Amidst An Opioid Crisis, Ketamine Has the Potential To Save Lives

    Ketamine for pain

    Multi-Day Low Dose Ketamine Infusion For The Treatment Of Complex Regional Pain Syndrome

    ketamine for chronic pain

    End Chronic Back Pain with Ketamine for a Fuller Life

    ketamine for pain

    What You Should Know About Rheumatoid Arthritis

    ketamine for pain

    Myofascial Pain Syndrome: Symptoms, Causes, and Treatment

    ketamine for pain

    A sweet reprieve: Ketamine helps to relive phantom limb pain

  • PTSD
    ketamine news

    Dispelling the Stigmas, Ketamine, and the Future of Mental Healthcare

    ketamine news

    A First of its Kind: Wellbeing Digital Sciences Delivers its “First Ketamine Treatment Under the Inpatient KITE Program”

    veterans day

    Veterans’ Day: What Does PTSD Look Like In Veterans?

    PTSD awareness month

    PTSD Awareness Month: What Can I Do To Help?

    Trump Orders ‘a lot’ of Ketamine for Depressed Veterans

    Will Ketamine Be A Breakthrough Drug for PTSD?

    Ketamine to treat ptsd

    PTSD Sufferers ‘Healed’ With New Ketamine Infusion Therapy?

    ketamine to treat PTSD

    VA Uses Ketamine To Treat PTSD Effectively

    ketamine to treat ptsd

    Ketamine can help treat PTSD

  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact
No Result
View All Result
ketamine.news
Home Featured

Beaumont launches study on whether two common drugs can treat COVID-19

Ketamine News by Ketamine News
May 6, 2020
in Featured, Ketamine in The News
0
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

Beaumont Hospital researchers are hoping that two common drugs can help treat COVID-19 patients.

The drugs are naltrexone and ketamine. Naltrexone is used to treat inflammatory pain conditions and addiction. Ketamine is an anesthetic that also has anti-inflammatory properties.

The study is called SINK COVID-19, or the Study of Immunomodulation using Naltrexone and Ketamine for COVID-19.

Dr. Matthew Sims, Director of Infectious Disease Research for Beaumont, said that researchers hope the two drugs can interrupt the severe, damaging immune system response that can occur in COVID-19 patients.

“The addition of these two medications, as immunomodulators, to the treatment regimen of patients with COVID-19 has potential to decrease the severity of this disease by reducing the autoimmune, hyperinflammatory stages of the virus which is destructive to normal tissue and, when unchecked, rapidly leads to death,” Sims said.

“This study is twofold. It’s looking at whether naltrexone can prevent progression to the worst forms of COVID, and whether ketamine can rescue people who have gotten worse.”

Sims said researchers will administer naltrexone to patients in the earlier stages of COVID-19. If the disease worsens, they’ll then receive ketamine.

Some patients enrolled in the study will receive a placebo rather than naltrexone, Sims said.

“These kinds of studies really have to be done that way, because if you don’t use a placebo, you’ll never really know,” Sims said. “Did the people get better because of the drug, or was there something else going on? You have to be able to control it against nothing, basically.”

Sims said researchers hope to recruit 500 volunteers for the study from Beaumont-Royal Oak. He said it’s unclear when they’ll be able to get enough participants, especially since COVID-19 cases are declining in Metro Detroit. However, Sims said they’ll be able to do an interim analysis once they have results from 75 patients.

Sims said naltrexone and ketamine are generally considered to be very safe drugs, and will be administered in lower-than-normal doses to COVID patients. He said he’s not aware of any other U.S. researchers who have looked into this drug combination as a possible COVID treatment.

“We did a search, we couldn’t find anything,” Sims said. “Nobody else seems to have looked at this.”

The study has received U.S. Food and Drug Administration approval. Dr. Annas Aljassem is a study co-investigator along with Sims. Investigative team members also include Dr. Carl Lauter and Dr. Levi Hall. It will be funded through the Beaumont Foundation, and several health system donors.

Direct link and credit to https://www.michiganradio.org/ for the original story:https://www.michiganradio.org/post/beaumont-launches-study-whether-two-common-drugs-can-treat-covid-19

Direct link to clinical trials: https://clinicaltrials.gov/ct2/show/NCT04365985

Tags: COVID-19 and Ketamine
Previous Post

Ketamine Therapy Essential Service During COVID-19 Pandemic

Next Post

The American Society of Ketamine Physicians (ASKP) Announces Name Change

Next Post
The American Society of Ketamine Physicians (ASKP) Announces Name Change

The American Society of Ketamine Physicians (ASKP) Announces Name Change

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • A Day in the Life
  • Esketamine
  • Featured
  • Ketamine Dictionary
  • Ketamine for Anxiety
  • Ketamine for Depression
  • Ketamine for Pain
  • Ketamine for PTSD
  • Ketamine in The News
  • Mental Health
  • Psychedelic Medicine
  • Suicide Prevention
  • Uncategorized
ketamine news

Categories

  • A Day in the Life
  • Esketamine
  • Featured
  • Ketamine Dictionary
  • Ketamine for Anxiety
  • Ketamine for Depression
  • Ketamine for Pain
  • Ketamine for PTSD
  • Ketamine in The News
  • Mental Health
  • Psychedelic Medicine
  • Suicide Prevention
  • Uncategorized

Recent Posts

  • Connecticut Approves a Bill That Could Pave Way for the Use of Psychedelic Substances to Treat Mental Health Illnesses
  • A Group of D.C. Advocacy Groups Have Joined Hands to Push For Drug Policy Reform in the Nation’s Capital
  • ‘Magic Mushrooms’ Look Set to Follow in the Footsteps of Cannabis
  • Bronner’s Magic Soaps Becomes The First Company to Offer Ketamine-Assisted Therapy as Part of Employees’ Health Benefits
  • Rhode Island Lawmakers Accelerate Drug Decriminalization Efforts
  • Chronic Pain
  • Contact
  • Depression
  • Home
  • PTSD
  • Video

© 2022 Ketamine News

No Result
View All Result
  • Home
  • Depression
  • Chronic Pain
  • PTSD
  • Video
  • Ketamine Directory
  • Ketamine Media
  • Contact

© 2022 Ketamine News

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In